We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MBC: REIMPORTATION, PRICE CONTROLS WILL STIFLE BIOTECH INDUSTRY
MBC: REIMPORTATION, PRICE CONTROLS WILL STIFLE BIOTECH INDUSTRY
April 9, 2004
Rather than looking to reimportation or price controls as solutions to the rising cost of prescription drugs, the U.S. should address the problem as a trade issue and work to ensure that European and other industrialized nations shoulder their fair share of the development burden, according to the Massachusetts Biotechnology Council (MBC).